| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446597 | European Journal of Cancer | 2012 | 7 Pages |
Abstract
L. brevis CD2 lozenges reduced the incidence of grade III and IV anticancer therapy-induced oral mucositis and were associated with a lower overall rate of mucositis and a higher rate of anticancer treatment completion.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Atul Sharma, G.K. Rath, S.P. Chaudhary, Alok Thakar, Bidhu Kalyan Mohanti, Sudhir Bahadur,